ArticleFrontiers in immunology2026

A novel region of the insulin B9-23 sequence is targeted by a HIP-reactive diabetogenic T cell clone.

Janet M Wenzlau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.